Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 89R13767 CMO-F | ||
| By: Alvarado, Cook | S.B. No. 1500 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to written protocols for certain nonprescription drugs | |
| under Medicaid and civil liability related to those protocols. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Subchapter B, Chapter 32, Human Resources Code, | |
| is amended by adding Section 32.0465 to read as follows: | |
| Sec. 32.0465. WRITTEN PROTOCOLS FOR CERTAIN | |
| NONPRESCRIPTION DRUGS; LIMITATION ON LIABILITY. (a) In this | |
| section: | |
| (1) "Health care provider" means a physician or other | |
| person who is licensed, certified, or otherwise authorized by this | |
| state's laws to prescribe a prescription drug in the ordinary | |
| course of business or practice of a profession. | |
| (2) "Medical director" means the medical director | |
| employed by the executive commissioner under Section 523.0054, | |
| Government Code. | |
| (3) "Nonprescription drug," "pharmacist," "pharmacy | |
| technician," "pharmacy technician trainee," "provide," and | |
| "written protocol" have the meanings assigned by Section 551.003, | |
| Occupations Code. | |
| (4) "Recipient" means a medical assistance recipient. | |
| (b) The medical director may issue a standing written | |
| protocol for a nonprescription drug to support recipient access to | |
| preventive care and improve recipient health during pregnancy and | |
| the preconception and postpartum periods. A written protocol the | |
| medical director issues under this subsection: | |
| (1) must: | |
| (A) include pharmacy instructions the medical | |
| director determines necessary; | |
| (B) identify the recipient population eligible | |
| to obtain a nonprescription drug under the written protocol; and | |
| (C) list each known contraindication; and | |
| (2) expires on the first anniversary of the date the | |
| medical director issues the written protocol. | |
| (c) The medical director is immune from civil liability for | |
| issuing a written protocol that complies with the requirements | |
| listed in Subsection (b). | |
| (d) A health care provider is immune from civil liability | |
| for issuing a written protocol for a nonprescription drug for a | |
| recipient that includes a list of each known contraindication. | |
| (e) A pharmacist, pharmacy technician, or pharmacy | |
| technician trainee is immune from civil liability for providing a | |
| nonprescription drug to a recipient in accordance with a written | |
| protocol described by Subsection (b) or (d). | |
| SECTION 2. If before implementing any provision of this Act | |
| a state agency determines that a waiver or authorization from a | |
| federal agency is necessary for implementation of that provision, | |
| the agency affected by the provision shall request the waiver or | |
| authorization and may delay implementing that provision until the | |
| waiver or authorization is granted. | |
| SECTION 3. The change in law made by this Act applies only | |
| to a cause of action that accrues on or after the later of the | |
| effective date of this Act or the date any necessary waiver or | |
| authorization described by Section 2 of this Act is granted. A | |
| cause of action that accrues before the later of those dates is | |
| governed by the law applicable to the cause of action immediately | |
| before that date, and that law is continued in effect for that | |
| purpose. | |
| SECTION 4. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.